Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate

被引:0
|
作者
Ivan Krečak
Sandra Celić-Bunikić
Marko Skelin
Marko Lucijanić
Srdan Verstovsek
Rajko Kušec
机构
[1] General Hospital of Šibenik-Knin County,Department of Internal Medicine
[2] University of Rijeka,School of Medicine
[3] General Hospital of Šibenik-Knin County,Department of Neurology
[4] General Hospital of Šibenik-Knin County,Pharmacy Department
[5] University of Rijeka,Department of Basic and Clinical Pharmacology With Toxicology, Faculty of Medicine
[6] University Hospital Dubrava,Division of Hematology
[7] University of Zagreb,School of Medicine
[8] The University of Texas MD Anderson Cancer Center,Department of Leukemia
来源
Annals of Hematology | 2022年 / 101卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1885 / 1886
页数:1
相关论文
共 50 条
  • [21] Glatiramer acetate: Mechanisms of action in multiple sclerosis
    Schrempf, Wiebke
    Ziemssen, Tjalf
    AUTOIMMUNITY REVIEWS, 2007, 6 (07) : 469 - 475
  • [22] Lipoatrophy in patients with multiple sclerosis on glatiramer acetate
    Edgar, CM
    Brunet, DG
    Fenton, P
    McBride, EV
    Green, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2004, 31 (01) : 58 - 63
  • [23] Glatiramer acetate therapy for multiple sclerosis: a review
    Perumal, Jai
    Filippi, Massimo
    Ford, Corey
    Johnson, Kenneth
    Lisak, Robert
    Metz, Luanne
    Tselis, Alexandros
    Tullman, Mark
    Khan, Omar
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (06) : 1019 - 1029
  • [24] Mechanisms of action of glatiramer acetate in multiple sclerosis
    Neuhaus, O
    Farina, C
    Wekerle, H
    Hohlfeld, R
    NEUROLOGY, 2001, 56 (06) : 702 - 708
  • [25] A longitudinal observational study of a cohort of patients with relapsingremitting multiple sclerosis treated with glatiramer acetate
    Debouverie, M.
    Moreau, T.
    Lebrun, C.
    Heinzlef, O.
    Brudon, F.
    Msihid, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (11) : 1266 - 1274
  • [26] Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate
    Chiarini, M.
    Sottini, A.
    Ghidini, C.
    Zanotti, C.
    Serana, F.
    Rottoli, M.
    Zaffaroni, M.
    Bergamaschi, R.
    Cordioli, C.
    Capra, R.
    Imberti, L.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (02) : 218 - 227
  • [27] Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis
    Bourdette, Dennis
    Hartung, Daniel
    JAMA NEUROLOGY, 2015, 72 (12) : 1411 - 1413
  • [28] Glatiramer acetate: successful desensitization for treatment of multiple sclerosis
    Bains, Sonia N.
    Hsieh, Fred H.
    Rensel, Mary R.
    Radojicic, Cristine
    Katz, Hary T.
    Inamdar, S. Rubina
    Lang, David M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 104 (04) : 321 - 325
  • [29] Lack of evidence for use of glatiramer acetate in multiple sclerosis
    Munari, LM
    LANCET NEUROLOGY, 2004, 3 (11): : 641 - 641
  • [30] The Use of Interferon Beta and Glatiramer Acetate in Multiple Sclerosis
    Goodin, Douglas S.
    SEMINARS IN NEUROLOGY, 2013, 33 (01) : 13 - 25